NCT04496141View on ClinicalTrials.gov

Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 antibody immunoassays

Different commercial SARS-CoV-2 antibody immunoassays

Trial Locations (1)

Unknown

Hong Kong Sanatorium & Hospital, Hong Kong

All Listed Sponsors
lead

Hong Kong Sanatorium & Hospital

INDUSTRY

NCT04496141 - Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19 | Biotech Hunter | Biotech Hunter